期刊文献+

非小细胞肺癌中甲胎蛋白受体表达的临床意义 被引量:3

Clinical significance of the expression of alpha-fetoprotein receptor in human non small cell lung cancer
下载PDF
导出
摘要 目的:研究非小细胞肺癌(NSCLC)中甲胎蛋白受体(alphafetoproteinreceptor,AFPR)表达的临床意义。方法:用免疫组织化学方法分析57例NSCLC组织、癌旁正常肺组织AFPR表达情况。结果:①NSCLC患者肿瘤组织中AFPR阳性率为40.4%(23/57)较正常肺组织15.8%(9/57)明显增高(P<0.05)。②腺癌及腺鳞癌AFPR阳性率59.4%(19/32)显著高于非腺癌16%(4/25)(P<0.05),腺癌AFPR表达与p53呈负相关(P<0.05)。③在不同年龄、不同性别、不同分期、有无淋巴结转移的不同肺癌组织中,AFPR表达阳性率均无显著性差异(P>0.05)。结论:NSCLC组织中AFPR表达明显高于癌旁正常肺组织,AFPR表达与肿瘤病理类型有一定关系。 Objective: To investigate the expression of alpha-fetoprotein receptor (AFPR) in human non-small cell lung cancer (NSCLC) and its clinical meaning. Methods: Immunohistochemical technique was used to analyze the expressions of AFPR in 57 lung cancer tissues and 57 paracancerous normal lung tissues with anti-AFPR antibody. Results: (1) The positive rate of AFPR expression was 40.4% (23/57)in cancer tissues. It was much higher than that in paracancerous normal tissues(15.8%, 9/57, P 〈0.05). (2)The positive rates of AFPR expression was significantly related to histological classification(P〈0.05). The AFPR expression in adenocarcinoma and adeno-squamous carcinoma was much higher than that in non adenocarcinoma [59.4% (19/32) vs 16% (4/25), P〈0.05]. The AFPR expression in adenocarcinoma was negatively correlated with p53 (P〈0.05). (3)The expression of AFPR was not significantly associated with age, sex, p-TNM stage, and lymph node metastasis of patients with lung adenocarcinoma(P〉0.05). Conclusion: AFPR expression in NSCLC tissues is much higher than that in paracancerous normal lung tissue. Expression level of AFPR correlates well with histological classification of NSCLC.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第7期602-604,共3页 Tumor
基金 上海市医苑新星培养计划
关键词 肺肿瘤 非小细胞肺 免疫组织化学 受体 甲胎蛋白 Lung neoplasms Carcinoma, non-small cell lung Immunohistochemistry Receptor, alpha-fetoprotein
  • 相关文献

参考文献10

  • 1MIZEJEWSKI G J.Alpha-fetoprotein binding proteins:Implications for transmembrane passage and subcellular localization[J].Life Sciences,1995,56 (1):1-9.
  • 2MIZEJEWSKI G J,MACCOLL R.Alpha-fetoprotein growth inhibitory peptides:Potential leads for cancer therapeutics[J].Mol Cancer Ther,2003,2(11):1243-1255.
  • 3MUEHLEMANN M,MILLER K D.Review of growth inhibitory peptide as a biotherapeutic agent for tumor growth,adhesion,and metastasis[J].Cancer Metastasis Rev,2005,24(3):441-467.
  • 4MIZEJEWSKI G J,BUTTERSTEIN G.Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides:review and prospects[J].Curr Protein Pept Sci,2006,7(1):73-100.
  • 5ZHU C Q,FIONA H,BLACKHALL M P.Skp2 gene copy number aberrations are common in non-small cell lung carcinoma,and its overexpression in tumors with ras mutation is a poor prognos tic marker[J].Clin Cancer Res,2004,10(6),1984-1991.
  • 6ESTEBAN C,TROJAN J,MACHO A,et al.Activation of an alpha-fetoprotein/receptor pathway in human normal and ma-ligant peripheral blood mononuclear cells[J].Leukemia,1993,7(11):1807-1816.
  • 7MORO R,TAMAOKI T,WEGMANN T G,et al.Monoclonal antibodies directed against a widespread oncofetal antigen:The alpha-fetoprotein receptor[J].Tumour Biol,1993,14 (2):116-130.
  • 8ALAVA M A,ITURRALDE M,LAMPREAVE F,et al.Specific uptake of alpha-fetoprotein and albumin by rat Morris7777 hepatoma cells[J].Tumour Biol,1999,20 (1):52-64.
  • 9KANEVSKY V Y,POZDNYAKOVA L P,AKSENOVA OA,et al.Isolation and characterization of AFP-binding proteins from tumor and fetal human tissues[J].Biochem Mol Biol Int,1997,41(6):1143-1151.
  • 10LiMS,LiPF,等.The promoting molecular mechanism of alphafetoprotein on the growth of human hepatoma Bel7402 cell line[J].World Journal of Gastroenterology,2002,8(3):469-475. 被引量:59

二级参考文献3

共引文献58

同被引文献64

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部